
Nexalin, Armada, Roze AI, Mattel, and Accenture lead market gains on key deals and earnings beats
On October 1, 2026, Nexalin Technology surged 76.4% after securing a 10-year exclusive deal for its medical device in South America. Armada Acquisition Corp. II jumped 42.9% following shareholder approval of its merger with Evernorth, expected to clo...





